معرفی
Jeph Herrin, PhD is an Assistant Professor of Medicine (Cardiology) and Internal Medicine at Yale School of Medicine, affiliated with the Department of Cardiovascular Medicine and the COPPER Center. He holds an adjunct appointment in Internal Medicine. His academic journey includes a PhD in Mathematics from the University of Virginia (1990), an MS in Mathematics from the same institution (1986), and a BS in Physics from Davidson College (1983).
His research focuses on healthcare outcomes, disparities in care, diabetes management, and clinical epidemiology. Key studies include investigations into racial disparities in healthcare access, long-term effects of antithrombotic therapies, and longitudinal trends in osteoporosis drug use. He collaborates frequently with leaders like Harlan Krumholz and Joseph Ross.
Recent work includes a phase 2 trial evaluating Paxlovid for long COVID symptoms, analyses of GLP-1 receptor agonist safety, and kidney outcomes in diabetes patients. His research bridges clinical informatics with implementation science, particularly in improving symptom management in oncology and hypertension treatment protocols in China. He is also involved in studies addressing rural-urban disparities in diabetes complications.
Dr. Herrin's work has been published in high-impact journals including JAMA, The Lancet Infectious Diseases, and Clinical Journal of the American Society of Nephrology. His research teams include experts in biostatistics, epidemiology, and health policy, reflecting a multidisciplinary approach to advancing healthcare equity and clinical outcomes.